Jinkui Wang
Impact in
-
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Renal cell carcinoma treatment 10
- Sarcoma Diagnosis and Treatment 7
- Prostate Cancer Treatment and Research 7
-
- Renal and related cancers 8
- Co-authors
- Zhaoxia Zhang (33 shared papers)Liming Jin (27 shared papers)Tao Mi (27 shared papers)Mujie Li (24 shared papers)Chenghao Zhanghuang (28 shared papers)Dawei He (27 shared papers)Xinming Li (1 shared paper)Wenjun Zhan (1 shared paper)
- Journals
- Frontiers in Public Health (12 papers)Scientific Reports (4 papers)PLoS ONE (3 papers)European Journal of Pharmacology (2 papers)BMC Urology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Jinkui Wang
78 papers receiving 648 citations
Peers
Comparison fields: 5 of 120
- Cancer Research 115
- Biomaterials 75
- Molecular Biology 281
- Pulmonary and Respiratory Medicine 116
- Biomedical Engineering 154
Countries citing papers authored by Jinkui Wang
This map shows the geographic impact of Jinkui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinkui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinkui Wang more than expected).
Fields of papers citing papers by Jinkui Wang
This network shows the impact of papers produced by Jinkui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinkui Wang. The network helps show where Jinkui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinkui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 113 | |
| 2 | 2022 | 53 | |
| 3 | 2022 | 45 | |
| 4 | 2015 | 39 | |
| 5 | Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ. | 2017 | 34 |
| 6 | 2023 | 25 | |
| 7 | 2022 | 24 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 14 | |
| 11 | 2022 | 11 | |
| 12 | 2024 | 11 | |
| 13 | 2019 | 11 | |
| 14 | 2010 | 11 | |
| 15 | 2023 | 10 | |
| 16 | 2022 | 9 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 8 | |
| 19 | 2023 | 8 | |
| 20 | 2022 | 8 |
About Jinkui Wang
Jinkui Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research and Aerospace Engineering, having authored 84 papers that have together received 654 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (12 papers), Renal cell carcinoma treatment (10 papers), Renal and related cancers (8 papers), Sarcoma Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (7 papers), Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Multiple and Secondary Primary Cancers (5 papers). The work is most often cited by research in Cancer Research (115 citations), Biomaterials (75 citations), Molecular Biology (281 citations), Pulmonary and Respiratory Medicine (116 citations) and Biomedical Engineering (154 citations). Jinkui Wang has collaborated with scholars based in China and United States. Frequent co-authors include Zhaoxia Zhang, Liming Jin, Tao Mi, Mujie Li, Chenghao Zhanghuang, Dawei He, Xinming Li, Wenjun Zhan, Yanli Li and Hong Chen. Their work appears in journals such as Frontiers in Public Health, Scientific Reports, PLoS ONE, European Journal of Pharmacology and BMC Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.